CAG
SRNE

Csenge Advisory Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Csenge Advisory Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,456
Closed -$45.6K – 650
2022
Q4 		$45.6K Hold
51,456
– – ﹤0.01% 584
2022
Q3 		$81K Hold
51,456
– – 0.01% 591
2022
Q2 		$103K Buy
+51,456
New +$103K 0.01% 557